Ketamine and Related Compounds – International Hybrid Conference

The Ketamine 2022 Conference will provide a platform for discussing the use of ketamine and related compounds for a variety of affective disorders and other psychiatric indications.

Leading researchers, clinicians and policy makers will present data from the latest trials and other studies. 

The meeting program will include novel data from clinical trials, mechanistic studies, preclinical data, biomarkers of treatment response, drug-assisted psychotherapy, policy and regulation. Speakers coming to Oxford include Chadi Abdallah, Jeffrey Becker, Lori Calabrese, Paul Glue, Alison McInnes, Roger McIntyre, Rodrigo Machado-Vieira, David Monks, Pouya Movahed Rad, Rebecca Price, Emma Robinson, Robert Schoevers, Jonathan Sporn, and Carlos Zarate. 

The Ketamine 2022 Conference offers participation options for both in-person and virtual attendees. For additional details on the programme, pricing and how to register, or if you have data that you would like to present, please go to www.ketamineconference.org.